In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae

Veterinary Microbiology

Volumn 137, Issue 3-4, 2009, Pages 282-289

  Liu, Jinlin ^a   Chen, Xia ^a   Tan, Chen ^a   Guo, Yi ^a   Chen, Yan ^a   Fu, Shulin ^a   Bei, Weicheng ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Actinobacillus pleuropnuemoniae; apxIVA; Virulence factor

Indexed keywords

APXIIC TOXIN; APXIVA TOXIN; REPEATS IN TOXIN TOXIN; TOXIN; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BLOOD CHEMISTRY; CLINICAL FEATURE; CONTAGIOUS PLEUROPNEUMONIA; CONTROLLED STUDY; HISTOPATHOLOGY; IN VIVO STUDY; NONHUMAN; PATHOGENICITY; PIGLET; PNEUMONIA; SCORING SYSTEM;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BACTERIAL PROTEINS; BLOOD GLUCOSE; LUNG; MICE; PNEUMONIA, BACTERIAL; SWINE; TIME FACTORS; VIRULENCE;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; MYCOPLASMA; NEGIBACTERIA; SUIDAE; SUS;

EID: 67349239324     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.01.011     Document Type: Article

References (24)

1. Bei W., He Q., Yan L., Fang L., Tan Y., Xiao S., Zhou R., Jin M., Guo A., Lv J., Huang H., and Chen H. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol. Lett. 243 (2005) 21-27
2. Boehm D.R., Welch A., and Snyder I.S. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58 (1990) 1959-1964
3. Boekema B.K., Kamp E.M., Smits M.A., and Stockhofe-Zurwieden N. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Vet. Microbiol. 100 (2004) 17-23
4. Bossé J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., and Langford P.R. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 4 (2002) 225-235
5. Frey J. Construction of a broad host range shuttle vector for gene cloning and expression in Actinobacillus pleuropneumoniae and other Pasteurellaceae. Res. Microbiol. 143 (1992) 263-269
6. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 3 (1995) 257-261
7. Fuller T.E., Thacker B.J., Duran C.O., and Mulks M.H. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine. Vaccine 18 (2000) 2867-2877
8. Hannan P.C., Bhogal B.S., and Fish J.P. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and virus. Res. Vet. Sci. 33 (1982) 76-88
9. Huang H., Zhou R., Chen M., Liu J., Xu X., and Chen H. Cloning and expression of the apxIVA gene of Actionbacillus pleuroneumoniae and development of an indirect ApxIVA-ELISA. Chin. J. Biotechnol. 21 (2005) 294-299 (in Chinese)
10. Itoh N., Kikuchi N., and Hiramune T. Biochemical changes in fowl serum during infection with Salmonella typhimurium. J. Vet. Med. Sci. 58 (1996) 1021-1023
11. Jansen R., Briaire J., Smith H.E., Dom P., Haesebrouck F., Kamp E.M., Gielkens A.L., and Smits M.A. Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils. Infect. Immun. 63 (1995) 27-37
12. Kamp E.M., Stockhofe-Zurwieden N., van Leengoed L.A., and Smits M.A. Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs. Infect. Immun. 65 (1997) 4350-4354
13. Lally E.T., Hill R.B., Kieba I.R., and Korostoff J. The interaction between RTX toxins and target cells. Trends Microbiol. 7 (1999) 356-361
14. Liang W., He Q., Liu Z., Chen H., Wu B., Xu X., and Li T. Cloning and expression of ApxII and development an indirect ELISA for detection of antibody against A. pleuropneumoniae. Chin. J. Vet. Sci. 25 (2005) 145-147 (in Chinese)
15. Lin L., Bei W., Sha Y., Liu J., Guo Y., Liu W., Tu S., He Q., and Chen H. Construction and immunogenecity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. FEMS Microbiol. Lett. 274 (2007) 55-62
16. Liu J., Chen X., Lin L., Tan C., Chen Y., Guo Y., Jin M., Guo A., Bei W., and Chen H. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 25 (2007) 7696-7705
17. Ohba T., Shibahara T., Kobayashi H., Takashima A., Nagoshi M., Osanai R., and Kubo M. Multifocal granulomatous hepatitis caused by Actinobacillus pleuropneumoniae serotype 2 in slaughter pigs. J. Comp. Pathol. 139 (2008) 61-66
18. Osicka R., Procházková K., Sulc M., Linhartová I., Havlícek V., and Sebo P. A novel "Clip-and-link" activity of repeat in toxin (RTX) proteins from Gram-negative pathogens. J. Biol. Chem. 279 (2004) 24944-24956
19. Reimer D., Frey J., Jansen R., Veit H.P., and Inzana T.J. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb. Pathog. 18 (1995) 197-209
20. Santos R.L., Tsolis R.M., Baumler A.J., and Adams L.G. Hematologic and serum biochemical changes in Salmonella ser Typhimurium-infected calves. Am. J. Vet. Res. 63 (2002) 1145-1150
21. Schaller A., Kuhn R., Kuhnert P., Nicolet J., Anderson T.J., MacInnes J.I., Segers R.P., and Frey J. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 145 (1999) 2105-2116
22. Schaller A., Kuhnert P., de la Puente-Redondo V.A., Nicolet J., and Frey J. Apx toxins in Pasteurellaceae species from animals. Vet. Microbiol. 74 (2000) 365-376
23. Welch R.A. RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. Curr. Top. Microbiol. Immunol. 257 (2001) 85-111
24. Welch R.A., Bauer M.E., Kent A.D., Leeds J.A., Moayeri M., Regassa L.B., and Swenson D.L. Battling against host phagocytes: the wherefore of the RTX family of toxins?. Infect. Agents Dis. 4 (1995) 254-272